文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

柬埔寨2017年疫苗前后出生队列乙型肝炎表面抗原血清流行率调查

Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
PubMed 文献 · Vaccine · 2019-07-05

该研究为柬埔寨全国性横断面多阶段整群血清学调查,纳入2010—2012年出生的5–7岁儿童及其母亲,采用快速即时检测估算HBsAg流行率并收集疫苗接种史。儿童HBsAg流行率为0.56%(95%CI:0.32%–0.98%),达到WHO区域2017年5岁儿童HBsAg流行率低于1%的目标;母亲流行率为4.39%(95%CI:3.53%–5.45%)。

要点

  • 儿童HBsAg流行率0.56%,已实现2017年低于1%的区域目标
  • 母亲HBsAg流行率4.39%,提示需常规筛查并衔接诊疗
  • 78.4%儿童接种首剂乙肝疫苗,其中58.7%在24小时内接种

核心结论

  • 柬埔寨5–7岁儿童HBsAg流行率为0.56%(95%CI:0.32%–0.98%),已达到WHO区域2017年5岁儿童低于1%的目标。
  • 母亲HBsAg流行率为4.39%(95%CI:3.53%–5.45%),提示应开展常规筛查并做好与诊疗服务的衔接。
  • 下一步应重点消除乙肝母婴传播,并与其他乙肝干预服务协同提高疫苗接种覆盖率。

研究设计与样本

  • 2017年在柬埔寨开展的全国性横断面多阶段整群调查。
  • 调查对象为2010—2012年出生的5–7岁儿童及其母亲,共纳入2,520名儿童和2,028名母亲。
  • HBsAg流行率采用快速即时检测估算,并收集疫苗接种史等人口学数据,分析时考虑复杂抽样设计。

主要发现

  • 儿童总体HBsAg流行率为0.56%(95%CI:0.32%–0.98%)。
  • 母亲HBsAg流行率为4.39%(95%CI:3.53%–5.45%)。
  • 未接种乙肝疫苗儿童的HBsAg流行率为4.62%(95%CI:1.31%–14.97%);母亲HBsAg阳性儿童的流行率为10.11%(95%CI:5.41%–18.11%)。
  • 78.4%的儿童接种了乙肝疫苗首剂,其中58.7%在24小时内接种。
  • 在家分娩或在「其他」地点分娩是儿童未及时(24小时内)接种首剂乙肝疫苗的独立危险因素。

关键数值与推荐

  • WHO区域2017年目标:5岁儿童HBsAg流行率低于1%,柬埔寨儿童0.56%(95%CI:0.32%–0.98%)已达该目标。
  • 儿童乙肝疫苗首剂接种率为78.4%,其中58.7%在24小时内完成接种。
  • 未接种儿童HBsAg流行率4.62%(95%CI:1.31%–14.97%),母亲HBsAg阳性儿童为10.11%(95%CI:5.41%–18.11%)。

临床怎么用

  • 以全国血清学数据评估乙肝免疫规划效果,确认儿童HBsAg流行率已达区域控制目标。
  • 对孕妇及育龄妇女开展HBsAg常规筛查,并衔接后续诊疗服务以阻断母婴传播。
  • 关注分娩地点等因素,改进首剂乙肝疫苗24小时内及时接种。
  • 将乙肝防控与其他提供乙肝干预的服务协同规划,推进2030年全球消除目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatitis B virus (HBV) infection is highly endemic in most low income countries including Cambodia. This nationwide serosurvey was conducted to assess the impact of hepatitis B vaccination and to determine whether Cambodia met the WHO regional 2017 target of hepatitis B surface antigen (HBsAg) seroprevalence less than 1% in five-year-old children. METHODS: A cross-sectional multi-stage cluster survey was conducted among children born during 2010-2012 and their mothers in Cambodia. HBsAg prevalence was estimated by rapid point-of-care testing, and demographic data, including vaccination history, was collected. Vaccine coverage in children and the prevalence of HBsAg among children and mothers was calculated taking into account the complex survey design. Factors associated with children's failure to receive timely (within 24 h) vaccination were analysed by multivariate logistic analysis. FINDINGS: A total of 2,520 children 5-7 years old and 2,028 mothers were recruited. In total, 78.4% of children received hepatitis B vaccination birth-dose (HepB-BD); of these, 58.7% were administered ≤ 24 h. Birth at home or "other" location were independent risk factors for children's failure to receive timely HepB-BD. Overall HBsAg seroprevalence was 4.39% (95%CI: 3.53%-5.45%) among mothers and 0.56% (95%CI: 0.32%-0.98%) among children. The prevalence among children without hepatitis B vaccination was 4.62% (95%CI: 1.31%-14.97%). Among children with a HBsAg-positive mother, prevalence was 10.11% (95%CI: 5.41%-18.11%). INTERPRETATION: Having achieved the 2017 target of less than 1% HBsAg prevalence among 5 years old children, Cambodia can now focus on eliminating mother-to-child transmission of HBV. Moreover, the high HBsAg prevalence among mothers suggests that routine screening with proper linkage to care and treatment is needed. Strengthening measures to improve vaccination coverage further and eliminate mother-to-child transmission by coordinated programming with other services offering additional HBV interventions will help move towards the global goal of hepatitis B elimination by 2030. FUNDING: As per sources of funding.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ork V, Woodring J, Shafiqul Hossain M, et al. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017. Vaccine. 2019. PMID: 31285088. doi:10.1016/j.vaccine.2019.06.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。